IFP Advisors’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

IFP Advisors’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-425	Closed	–	–	4205
2018 Q2	$0	Buy	425 +125	+42%	+$103	﹤0.01%	4284
2018 Q1	$0	Hold	300	–	–	﹤0.01%	3938
2017 Q4	$0	Sell	300 -1,136	-79%	-$1.86K	﹤0.01%	4426
2017 Q3	$3K	Hold	1,436	–	–	﹤0.01%	3708
2017 Q2	$2K	Sell	1,436 -1,000	-41%	-$1.44K	﹤0.01%	3840
2017 Q1	$5K	Buy	2,436 +631	+35%	+$2.37K	﹤0.01%	3375
2016 Q4	$8K	Buy	1,805 +1,500	+492%	+$7.12K	﹤0.01%	3091
2016 Q3	$1K	Hold	305	–	–	﹤0.01%	3869
2016 Q2	$1K	Buy	+305	New	+$1.15K	﹤0.01%	3795

Other funds holding ARLZ

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors's ARLZ Position: Q3 2018 in Review

IFP Advisors sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 425 shares.

IFP Advisors first reported a position in ARLZ in Q2 2016 and held it in 9 quarters. The position peaked at $8K in Q4 2016. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

IFP Advisors reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
IFP Advisors sold 425 Aralez Pharmaceuticals Inc. shares in Q3 2018.
IFP Advisors first reported a position in Aralez Pharmaceuticals Inc. in Q2 2016 and held it in 9 quarters.
IFP Advisors's Aralez Pharmaceuticals Inc. position peaked at $8K in Q4 2016.
4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on IFP Advisors's 13F filing for Q3 2018, filed 25 Oct 2018.